| Record ID | marc_loc_updates/v38.i33.records.utf8:30881173:1430 |
| Source | Library of Congress |
| Download Link | /show-records/marc_loc_updates/v38.i33.records.utf8:30881173:1430?format=raw |
LEADER: 01430nam a22003258a 4500
001 2010031178
003 DLC
005 20100810112402.0
008 100722s2010 nyu b 001 0 eng
010 $a 2010031178
020 $a9781617615856 (softcover)
035 $a(DNLM)101536482
040 $aDNLM/DLC$cDLC
042 $apcc
050 00 $aRC685.C6$bC575 2010
060 10 $aWG 300
082 00 $a616.1/23061$222
245 00 $aClopidogrel response in acute coronary syndrome :$bclinical implications and emerging therapies /$cAntonio de Miguel Castro ... [et al.].
260 $aHauppauge, N.Y. :$bNova Science Publishers,$cc2010.
263 $a1103
300 $ap. ;$ccm.
504 $aIncludes bibliographical references and index.
505 0 $aResistance/variable response to clopidogrel : does it exist? -- Mechanisms of variable response to clopidogrel -- Is it possible to accurately assess the inhibitory effect of antiplatelet drugs? -- Clinical implications of variable response to clopidogrel -- What to do with patients with reduced response to clopidogrel therapy? -- Emerging therapies.
650 0 $aClopidogrel.
650 0 $aCoronary heart disease$xChemotherapy.
650 12 $aAcute Coronary Syndrome$xdrug therapy.
650 22 $aPlatelet Aggregation Inhibitors$xtherapeutic use.
650 22 $aTiclopidine$xpharmacology.
650 22 $aTiclopidine$xtherapeutic use.
700 1 $aMiguel Castro, Antonio de.